NA Proactive news snapshot: Endeavour Mining,XPhyto Therapeutics, Lexaria Bioscience, Arcadia Biosciences …

Endeavour Mining Corporation (TSE:EDV) (OTCMKTS:EDVMF) has revealed it is to combine with SEMAFO Inc (TSE:SMF) in a C$1 billion deal which will create a leading West Africa-based gold producer generating over 1 million ounces a year. The merger brings together six mines with strong cash flow into one portfolio, the opportunity to optimize assets, and a growth pipeline. Both company's boards have unanimously approved the transaction. Under the deal, each SEMAFO shareholder will receive 0.1422 Endeavour shares, representing a premium of 27.2% based on the 20-day volume-weighted average price of both companies for the period to March 20 this year. XPhyto Therapeutics Corp (CSE:XPHY) updated investors with regards to its infectious disease program, particularly as it pertains to combating the coronavirus (COVID-19) pandemic. In a statement, XPhyto said its wholly-owned German subsidiary Vektor Pharma TF GmbH, has struck a binding standstill agreement with a European biotechnology company for developing a low-cost, real-time oral pathogen screening platform. The enzyme-based platform was designed for species-specific bacterial pathogen detection in humans and will be expanded to include viral pathogen detection capability. No training is required to operate the test, the company said. Lexaria Bioscience Corp (CSE:LXX) (OTCMKTS:LXRP) told investors Monday that it has broadened the scope of its pharmaceutical subsidiary in a bid to help assist in the global fight against coronavirus. The company’s subsidiary Lexaria Pharmaceutical Corp will look at how the parent company’s DehydraTECH drug delivery platform could improve delivery and effectiveness of antiviral drugs to treat coronavirus. Kelowna, British Columbia-based Lexaria said it plans to expand collaboration with leading laboratories in North America and internationally “as soon as possible.” Arcadia Biosciences Inc (NASDAQ:RKDA), the crop science firm, has announced a tie-up with Vivion Specialties Inc (VSI) to distribute its first Hawaiian grown and extracted ingredients throughout North America. The new partnership is between Vivion and Archipelago Ventures - the firm's joint venture with Legacy Ventures Hawaii to grow and extract high-quality hemp and derivatives on the islands. Allot Ltd (NASDAQ:ALLT) has been chosen by semiconductor manufacturer Broadcom Inc (NASDAQ:AVGO) as the recommended vendor to provide a transition path from the discontinued line of PacketShaper network optimizing products to the Allot Secure Service Gateway. Broadcom acquired the enterprise security business of Symantec Corporation back in November, and the company opted to end PacketShaper on March 31 and concentrate its investment in the enterprise security software market. That’s where Allot comes in. Under the partnership agreement, Allot is offering attractive financial terms and discounts on products replacement to help customers transition from PacketShaper to equivalent Allot products. The terms will be offered through 2020, the company said.  CytoDyn Inc (OTCMKTS:CYDY) announced Monday that two more coronavirus (COVID-19) patients have been treated with the company’s drug leronlimab since Thursday, bringing the number of patients treated with the drug to four. The use of leronlimab, which has other therapeutic indications as a treatment for HIV and certain breast cancers, is being administered under an emergency Investigational New Drug Application recently granted by the US Food and Drug Administration.  The new patients, like the two before them, are being treated at a leading New York City hospital, the company said. Mota Ventures Corp (CSE:MOTA) (OTCMKTS:PEMTF) said Monday that it is launching an immune support CBD line inspired by the traction it is getting from the March 14 launch of its Pure Herbal Immunity Blend, which is marketed under its First Class brand. In a statement, the Vancouver-based company said its all-natural Immunity Blend snapped up 1,838 new customers within a week. The formulation includes 100% pure essential oils, including cinnamon leaf, lemon, clove bud, lime, eucalyptus globulus, rosemary, peppermint, spearmint and oregano, the company said. Parallax Health Sciences Inc (OTCMKTS:PRLX) announced Monday it is accepting orders for its coronavirus Point-of-Care diagnostics kits for US medical practices, hospitals, nursing operations, emergency centers, and nursing homes.  In a statement, the company also said it is providing immediate availability and access to Personal Protection Equipment (PPE) including, but not limited to, FDA-approved medical masks, protective sterile gowns, eye-protecting goggles, face shields, ventilators, and other medical grade equipment. Mandalay Resources Corp (TSE:MND) (OTCMKTS:MNDJF) told investors that the coronavirus pandemic has not impacted its production or supply chain so far There has been an outbreak in all the countries where Mandalay operates - Canada, Australia, Sweden and Chile - but none of its employees and contractors have been diagnosed with the virus, the group said in a statement. mCloud Technologies Corp (CVE:MCLD) (OTCMKTS:MCLDF) announced Monday it is “evaluating alternative arrangements” with BuildingIQ (ASX:BIQ), an Australia-listed company that mCloud had been making plans to acquire.  In a statement, mCloud said it has identified “material misrepresentations” during the due diligence process. Phunware, Inc. (NASDAQ:PHUN), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands worldwide, announced that it has entered into a financing transaction for the issuance of a series of senior convertible notes in the aggregate original principal amount of $3 million and a maturity date of December 31, 2021 with an institutional investor. It said it will receive approximately $2.564 million in net proceeds at closing, after deducting placement agent fees, The company added that it can pay off the notes either in cash or by selling securities, while holders of the notes will have the option to convert as desired at $3.00 per share or higher subject to adjustments. NetCents Technology Inc. (CSE:NTC) announced that, further to the management cease trade order (MCTO) issued by the British Columbia Securities Commission on March 4, 2020, in connection with a delay by the company in filing its annual financial statements before the prescribed deadline of February 28, 2019, it continues to work closely with its auditor and expects to make the required filings on or before April 15, 2020. Ximen Mining Corp (CVE:XIM) said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement, announced on March 20, 2020, which will see the issue of 454,545 shares at a purchase price of 33 cents each, together with 454,545 share purchase warrants at an exercise price of 55 cents each for a three-year period, with one placee. Explorex Resources Inc. (CSE:EX)) (OTCMKTS:EXPXF) has announced the closing of its non-brokered financing consisting of to 2,272,900 common shares priced at $0.22 per each, as previously announced on February 3, and March 11, 2020, for aggregate gross proceeds of $500,038. The funds received will be used for general working capital and for the payment to Origen Resources Inc. under the proposed Plan of Arrangement, which received the final order from the Supreme Court of British Columbia on March 13, 2020. Getchell Gold Corp. (CSE:GTCH) (OTCMKTS:GGLDF), a leading Nevada focused Gold and Copper exploration company, today announced that its common stock has been approved for trading on the OTCQB Venture Market under the ticker symbol "GGLDF", effective as of the opening of trading today, March 23, 2020. The company will continue to trade on the Canadian Securities Exchange under the symbol "GTCH". "It is intended that the OTCQB Venture Market will provide our current and future shareholder base with increased visibility and transparency through high-quality disclosure, transparent trading and ease of access to Company information. This is an exciting development and we are pleased to commence trading on the OTCQB", said Bill Wagener, CEO & Director of Getchell Gold. Nuvo Pharmaceuticals Inc. (CVE:NRI) (OTCMKTS:NRIFF), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, said that Jesse Ledger, its president & chief executive officer and Kelly Demerino, its interim chief financial officer will present live at LifeSciencesInvestorForum.com on March 26 at 10.00am Eastern Time (ET).  The live, interactive online event, organised by part of OTC Markets Group will see investors invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. LINK: https://tinyurl.com/March26LSIF Emmaus Life Sciences, Inc. (OTCMKTS:EMMA), a leader in sickle cell disease treatment, announced that Dr. Yutaka Niihara, its chairman and chief executive officer, and Jay Sherwood, its chief financial officer, will also present live at LifeSciencesInvestorForum.com on March 26 at 11.00am ET. LINK: https://tinyurl.com/032620LSIF And RedHill Biopharma Ltd. (NASDAQ:RDHL), a specialty biopharmaceutical company focused on gastrointestinal diseases, said that its chief business officer, Guy Goldberg will also present a corporate overview at the virtual Life Sciences Investor Forum on Thursday, March 26, at 9:30am ET. The live broadcast and Q&A session can be accessed via the company's website, http://ir.redhillbio.com/events.